Ibutamoren (MK-677) 10 mg – 100 Capsules

Biochem Ibutamoren (MK-677) 10 mg – 100 Capsules | Oral Ghrelin Receptor Agonist and Growth Hormone Secretagogue

Biochem Ibutamoren (MK-677) 10 mg – 100 Capsules is an oral capsule product. This product contains ibutamoren, also known as MK-677, a nonpeptide growth hormone secretagogue developed to investigate growth hormone regulation through activation of the ghrelin receptor.

Biochem Ibutamoren contains 10 mg of ibutamoren per capsule, with 100 capsules per package, representing 1,000 mg (1 gram) of stated active ingredient per package.

Ibutamoren belongs to a class of compounds known as growth hormone secretagogues. These substances stimulate signaling pathways involved in the release of endogenous growth hormone.

Unlike recombinant human growth hormone (somatropin), ibutamoren does not directly supply growth hormone to the body. Instead, it interacts with receptors involved in regulating the body's own growth hormone secretion.

Ibutamoren acts as an agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a), commonly known as the ghrelin receptor.

Ghrelin is an endogenous hormone involved in appetite regulation, energy balance, and growth hormone secretion.

Activation of GHS-R1a can stimulate growth hormone release from the anterior pituitary gland.

In clinical investigations, ibutamoren has been associated with increased circulating growth hormone and insulin-like growth factor 1 (IGF-1) concentrations.

However, increased hormone concentrations do not independently establish improvements in physical performance, functional strength, recovery, or long-term health.

Ibutamoren has been studied in several human populations, including older adults and individuals with conditions associated with altered growth hormone physiology.

Clinical studies have examined outcomes such as growth hormone secretion, IGF-1 concentrations, body composition, and metabolic responses.

Some studies observed increases in fat-free mass, but these findings did not consistently translate into improvements in muscle strength or physical function.

Ibutamoren has also been associated with increased appetite, fluid retention, altered glucose regulation, and reduced insulin sensitivity.

Its potential effects on blood glucose and insulin resistance are especially important because growth hormone signaling can influence carbohydrate metabolism.

Ibutamoren is frequently discussed alongside selective androgen receptor modulators (SARMs), but ibutamoren is not a SARM.

Unlike andarine (S-4), ostarine (MK-2866), and ligandrol (LGD-4033), ibutamoren does not primarily act through androgen receptor modulation.

Instead, its primary pharmacological mechanism involves activation of the ghrelin receptor and stimulation of endogenous growth hormone secretion.

Ibutamoren is not testosterone, an anabolic-androgenic steroid, recombinant growth hormone, or an IGF-1 preparation.

Despite its presence in online discussions involving bodybuilding, muscle development, sleep, recovery, and performance, ibutamoren has no established approved therapeutic indication.

Its long-term safety and clinical effectiveness for these purposes have not been adequately demonstrated.

Ibutamoren is prohibited in competitive sport under World Anti-Doping Agency rules.

The Biochem brand name does not independently establish pharmaceutical approval, manufacturing quality, analytical purity, or clinical suitability.

1. Activates the Ghrelin Receptor

Ibutamoren acts as an agonist of GHS-R1a, a receptor involved in the regulation of growth hormone secretion and appetite.

This receptor is activated naturally by ghrelin, a hormone produced primarily in the gastrointestinal system.

Through interaction with GHS-R1a, ibutamoren influences endocrine signaling pathways associated with growth hormone release.

2. Stimulates Endogenous Growth Hormone Secretion

Growth hormone is produced and released by the anterior pituitary gland.

Ibutamoren can stimulate endogenous growth hormone secretion through ghrelin receptor activation.

This differs from administering recombinant human growth hormone, which directly introduces the hormone into systemic circulation.

The resulting endocrine response depends on individual physiology and other regulatory factors.

3. Can Increase Circulating IGF-1 Concentrations

Growth hormone influences the production of insulin-like growth factor 1, particularly through hepatic signaling.

Human studies of ibutamoren have reported increases in circulating IGF-1 concentrations.

IGF-1 is involved in growth, tissue maintenance, and metabolic regulation.

However, increased IGF-1 concentrations should not be interpreted as proof of improved athletic performance, recovery, or long-term clinical outcomes.

4. Has Been Investigated in Body Composition Research

Ibutamoren has been studied for its effects on body composition in selected human populations.

Some clinical investigations reported increases in fat-free mass.

However, changes in fat-free mass did not consistently produce corresponding improvements in muscle strength or functional performance.

These findings do not establish ibutamoren as an effective or safe treatment for muscle development.

5. Influences Appetite and Energy Regulation

The ghrelin receptor plays an important role in appetite regulation and energy balance.

Because ibutamoren activates this receptor, increased appetite has been observed in clinical investigations.

Changes in appetite and food intake can influence body weight and metabolic outcomes.

Such effects should not be interpreted as evidence of improved nutritional status or beneficial body composition changes in every individual.

6. Has Been Studied in Aging and Growth Hormone Physiology

Ibutamoren has been investigated in older adults and other selected populations to evaluate growth hormone secretion, IGF-1 concentrations, and physiological outcomes.

Although some studies demonstrated endocrine changes, the evidence has not established sufficient long-term clinical benefit and safety to support an approved therapeutic indication.

7. Has Important Metabolic and Fluid-Retention Safety Concerns

Ibutamoren may cause increased appetite, fluid retention, peripheral edema, fatigue, and muscle or joint discomfort.

Clinical studies have also identified concerns involving increased blood glucose and reduced insulin sensitivity.

These effects are particularly relevant to individuals with diabetes, prediabetes, cardiovascular disease, or conditions aggravated by fluid retention.

Long-term risks associated with sustained growth hormone and IGF-1 stimulation remain insufficiently characterized.

Ibutamoren has no established approved indication for muscle growth, athletic performance, sleep improvement, anti-aging treatment, or growth hormone replacement. The 10 mg capsule strength describes the product presentation and does not establish a medically validated or safe human dose.

Step 1 – Oral Capsule Administration and Absorption

Ibutamoren is an orally active nonpeptide growth hormone secretagogue.

Following oral administration, it can be absorbed through the gastrointestinal tract and enter systemic circulation.

The absorption characteristics of this particular Biochem capsule formulation have not been independently established.

Step 2 – Distribution and Ghrelin Receptor Interaction

Following absorption, ibutamoren reaches tissues involved in growth hormone regulation.

It interacts with the growth hormone secretagogue receptor GHS-R1a.

This receptor is involved in signaling pathways that regulate endocrine and metabolic functions.

Step 3 – Stimulation of Pituitary Growth Hormone Release

Activation of GHS-R1a can stimulate signaling associated with growth hormone secretion from the anterior pituitary gland.

The response is influenced by the body's existing endocrine regulatory mechanisms.

Step 4 – Changes in Growth Hormone and IGF-1 Signaling

Increased endogenous growth hormone secretion can influence circulating IGF-1 concentrations.

These hormones participate in numerous metabolic and physiological processes.

Changes in circulating hormone levels do not guarantee beneficial clinical outcomes.

Step 5 – Metabolism and Elimination

Following systemic exposure, ibutamoren undergoes metabolic processing and elimination.

Published pharmacokinetic observations do not independently establish the characteristics of this specific Biochem capsule formulation.

The precise metabolic pathways, elimination behavior, and potential drug interactions require additional characterization.

The Biochem Ibutamoren 10 mg capsule presentation includes the following characteristics:

• Ibutamoren (MK-677) as the stated active compound.
• 10 mg per capsule.
• 100 capsules per package.
• 1,000 mg total stated active ingredient content.
• Oral capsule presentation.
• Nonpeptide growth hormone secretagogue classification.
• Ghrelin receptor agonist activity.
• GHS-R1a receptor interaction.
• Stimulation of endogenous growth hormone secretion.
• Increased IGF-1 concentrations observed in clinical studies.
• No direct administration of recombinant growth hormone.
• No primary androgen receptor modulation.
• Not classified as a SARM.
• Human clinical investigations involving growth hormone physiology.
• Human clinical investigations involving body composition.
• Reported increases in fat-free mass in selected studies.
• No consistently demonstrated improvement in functional strength.
• Increased appetite observed in clinical studies.
• Potential fluid retention and peripheral edema.
• Potential impairment of glucose regulation.
• Potential reduction in insulin sensitivity.
• No established approved therapeutic indication.
• Inadequately characterized long-term human safety.
• Prohibited status under WADA rules.
• Capsule excipients requiring confirmation.
• Identity, purity, and content uniformity requiring independent analytical verification.

The precise excipient composition, capsule appearance, salt form, manufacturing specifications, purity, and analytical content of Biochem Ibutamoren 10 mg have not been independently verified.

The product is described as containing 100 capsules of 10 mg each, representing 1,000 mg total stated active ingredient. If the formulation uses ibutamoren mesylate, the manufacturer should clarify whether the stated strength refers to the free-base equivalent or the mass of the mesylate salt.

This description does not establish regulatory authorization, clinical safety, or suitability for human administration.

United States

Biochem Ibutamoren 10mg, Biochem MK677 10mg, Ibutamoren 10mg 100 capsules, MK677 100 capsules, Ibutamoren United States, Ibutamoren growth hormone secretagogue, MK677 ghrelin receptor agonist, Ibutamoren molecular formula, Ibutamoren chemical structure, MK677 GHS-R1a receptor activity, Ibutamoren pharmacology, Ibutamoren clinical studies, MK677 growth hormone secretion, Ibutamoren IGF1 signaling, Ibutamoren glucose metabolism, MK677 safety concerns, Ibutamoren clinical evidence, Ibutamoren capsule specifications.

Canada

English: Biochem Ibutamoren 10mg Canada, MK677 10mg Canada, Ibutamoren 100 capsules, Ibutamoren growth hormone secretagogue, ghrelin receptor agonist, Ibutamoren properties, MK677 pharmacology, Ibutamoren molecular structure, MK677 GHS-R1a receptor, Ibutamoren clinical studies, MK677 IGF1 signaling, Ibutamoren glucose regulation, MK677 safety information, Ibutamoren clinical evidence.

French: Biochem Ibutamoren 10 mg Canada, MK677 10 mg, Ibutamoren 100 capsules, sécrétagogue de l'hormone de croissance, agoniste du récepteur de la ghréline, propriétés de l'ibutamorène, pharmacologie du MK677, récepteur GHS-R1a, structure moléculaire, sécrétion de l'hormone de croissance, facteur de croissance IGF-1, études cliniques, métabolisme du glucose, résistance à l'insuline, informations de sécurité.

United Kingdom

Biochem Ibutamoren 10mg UK, Ibutamoren MK677 UK, Ibutamoren 100 capsules, growth hormone secretagogue, ghrelin receptor agonist, MK677 pharmacology, Ibutamoren chemical structure, GHS-R1a receptor activation, Ibutamoren clinical studies, MK677 growth hormone secretion, Ibutamoren IGF1 levels, MK677 glucose metabolism, Ibutamoren safety profile, Ibutamoren clinical evidence.

Germany

Biochem Ibutamoren 10 mg Deutschland, Ibutamoren MK677, Ibutamoren 100 Kapseln, Wachstumshormon-Sekretagogum, Ghrelinrezeptor-Agonist, Ibutamoren Eigenschaften, MK677 Wirkungsmechanismus, GHS-R1a Rezeptor, Ibutamoren Molekülstruktur, klinische Studien, Wachstumshormonfreisetzung, IGF-1 Spiegel, Glukosestoffwechsel, Insulinresistenz, Sicherheitsinformationen.

France

Biochem Ibutamoren 10 mg France, Ibutamoren MK677, Ibutamoren 100 gélules, sécrétagogue de l'hormone de croissance, agoniste du récepteur de la ghréline, propriétés de l'ibutamorène, mécanisme d'action du MK677, récepteur GHS-R1a, structure moléculaire, études cliniques, sécrétion de l'hormone de croissance, taux d'IGF-1, métabolisme du glucose, résistance à l'insuline, informations de sécurité.

Spain

Biochem Ibutamoren 10 mg España, Ibutamoren MK677, Ibutamoren 100 cápsulas, secretagogo de hormona de crecimiento, agonista del receptor de grelina, propiedades del ibutamoren, mecanismo de acción del MK677, receptor GHS-R1a, estructura molecular, estudios clínicos, secreción de hormona de crecimiento, niveles de IGF-1, metabolismo de glucosa, resistencia a la insulina, información de seguridad.

Italy

Biochem Ibutamoren 10 mg Italia, Ibutamoren MK677, Ibutamoren 100 capsule, secretagogo dell'ormone della crescita, agonista del recettore della grelina, proprietà dell'ibutamoren, meccanismo d'azione MK677, recettore GHS-R1a, struttura molecolare, studi clinici, secrezione dell'ormone della crescita, livelli di IGF-1, metabolismo del glucosio, resistenza insulinica, informazioni di sicurezza.

Portugal

Biochem Ibutamoren 10 mg Portugal, Ibutamoren MK677, Ibutamoren 100 cápsulas, secretagogo da hormona de crescimento, agonista do recetor da grelina, propriedades do ibutamoren, mecanismo de ação do MK677, recetor GHS-R1a, estrutura molecular, estudos clínicos, secreção da hormona de crescimento, níveis de IGF-1, metabolismo da glicose, resistência à insulina, informações de segurança.

Netherlands

Biochem Ibutamoren 10 mg Nederland, Ibutamoren MK677, Ibutamoren 100 capsules, groeihormoonsecretagoog, ghrelinreceptoragonist, eigenschappen van ibutamoren, werkingsmechanisme MK677, GHS-R1a receptor, moleculaire structuur, klinische studies, groeihormoonafgifte, IGF-1 niveaus, glucosemetabolisme, insulineresistentie, veiligheidsinformatie.

Belgium

Biochem Ibutamoren 10 mg België, Ibutamoren 10 mg Belgique, Ibutamoren MK677, Ibutamoren 100 capsules, groeihormoonsecretagoog, sécrétagogue de l'hormone de croissance, ghrelinreceptoragonist, agoniste du récepteur de la ghréline, eigenschappen van ibutamoren, propriétés de l'ibutamorène, GHS-R1a receptor, récepteur GHS-R1a, groeihormoonafgifte, sécrétion de l'hormone de croissance, insulineresistentie, résistance à l'insuline.

Switzerland

Biochem Ibutamoren 10 mg Schweiz, Ibutamoren 10 mg Suisse, Ibutamoren MK677, Ibutamoren 100 Kapseln, Ibutamoren 100 gélules, Wachstumshormon-Sekretagogum, sécrétagogue de l'hormone de croissance, Ghrelinrezeptor-Agonist, agoniste du récepteur de la ghréline, GHS-R1a Rezeptor, récepteur GHS-R1a, Wachstumshormonfreisetzung, sécrétion de l'hormone de croissance, IGF-1 Spiegel, taux d'IGF-1, Sicherheitsinformationen.

Austria

Biochem Ibutamoren 10 mg Österreich, Ibutamoren MK677, Ibutamoren 100 Kapseln, Wachstumshormon-Sekretagogum, Ghrelinrezeptor-Agonist, Ibutamoren Eigenschaften, MK677 Wirkungsmechanismus, GHS-R1a Rezeptor, Molekülstruktur, klinische Forschung, Wachstumshormonfreisetzung, IGF-1 Spiegel, Glukosestoffwechsel, Insulinresistenz, Sicherheitsinformationen.

Sweden

Biochem Ibutamoren 10 mg Sverige, Ibutamoren MK677, Ibutamoren 100 kapslar, tillväxthormonsekretagog, ghrelinreceptoragonist, ibutamoren egenskaper, MK677 verkningsmekanism, GHS-R1a receptor, molekylstruktur, kliniska studier, tillväxthormonfrisättning, IGF-1 nivåer, glukosmetabolism, insulinresistens, säkerhetsinformation.

Norway

Biochem Ibutamoren 10 mg Norge, Ibutamoren MK677, Ibutamoren 100 kapsler, veksthormonsekretagog, ghrelinreseptoragonist, ibutamoren egenskaper, MK677 virkningsmekanisme, GHS-R1a reseptor, molekylstruktur, kliniske studier, veksthormonfrigjøring, IGF-1 nivåer, glukosemetabolisme, insulinresistens, sikkerhetsinformasjon.

Denmark

Biochem Ibutamoren 10 mg Danmark, Ibutamoren MK677, Ibutamoren 100 kapsler, væksthormonsekretagog, ghrelinreceptoragonist, ibutamoren egenskaber, MK677 virkningsmekanisme, GHS-R1a receptor, molekylstruktur, kliniske studier, væksthormonfrigivelse, IGF-1 niveauer, glukosemetabolisme, insulinresistens, sikkerhedsinformation.

Finland

Biochem Ibutamoren 10 mg Suomi, Ibutamoren MK677, Ibutamoren 100 kapselia, kasvuhormonin eritystä stimuloiva aine, greliinireseptorin agonisti, ibutamoreenin ominaisuudet, MK677 vaikutusmekanismi, GHS-R1a reseptori, molekyylirakenne, kliiniset tutkimukset, kasvuhormonin eritys, IGF-1 pitoisuudet, glukoosiaineenvaihdunta, insuliiniresistenssi, turvallisuustiedot.

Poland

Biochem Ibutamoren 10 mg Polska, Ibutamoren MK677, Ibutamoren 100 kapsułek, sekretagog hormonu wzrostu, agonista receptora greliny, właściwości ibutamorenu, mechanizm działania MK677, receptor GHS-R1a, struktura molekularna, badania kliniczne, wydzielanie hormonu wzrostu, poziom IGF-1, metabolizm glukozy, insulinooporność, informacje o bezpieczeństwie.

Czech Republic

Biochem Ibutamoren 10 mg Česko, Ibutamoren MK677, Ibutamoren 100 kapslí, sekretagog růstového hormonu, agonista receptoru ghrelinu, vlastnosti ibutamorenu, mechanismus účinku MK677, receptor GHS-R1a, molekulární struktura, klinické studie, sekrece růstového hormonu, hladiny IGF-1, metabolismus glukózy, inzulinová rezistence, bezpečnostní informace.

Romania

Biochem Ibutamoren 10 mg România, Ibutamoren MK677, Ibutamoren 100 capsule, secretagog al hormonului de creștere, agonist al receptorului grelinei, proprietăți ibutamoren, mecanism de acțiune MK677, receptor GHS-R1a, structură moleculară, studii clinice, secreția hormonului de creștere, niveluri IGF-1, metabolismul glucozei, rezistență la insulină, informații de siguranță.

Greece

Biochem Ibutamoren 10 mg Ελλάδα, ιβουταμορένη MK677, Ibutamoren 100 κάψουλες, εκκριταγωγό αυξητικής ορμόνης, αγωνιστής υποδοχέα γκρελίνης, ιδιότητες ιβουταμορένης, μηχανισμός δράσης MK677, υποδοχέας GHS-R1a, μοριακή δομή, κλινικές μελέτες, έκκριση αυξητικής ορμόνης, επίπεδα IGF-1, μεταβολισμός γλυκόζης, αντίσταση στην ινσουλίνη, πληροφορίες ασφάλειας.

Ireland

Biochem Ibutamoren 10mg Ireland, Ibutamoren MK677 Ireland, Ibutamoren 100 capsules, growth hormone secretagogue, ghrelin receptor agonist, MK677 pharmacology, Ibutamoren molecular structure, GHS-R1a receptor activity, Ibutamoren clinical studies, MK677 growth hormone secretion, Ibutamoren IGF1 levels, MK677 glucose metabolism, Ibutamoren safety information, limited long-term human evidence.

Colombia

Biochem Ibutamoren 10 mg Colombia, Ibutamoren MK677 Colombia, Ibutamoren 100 cápsulas, ibutamoren 10 mg, secretagogo de hormona de crecimiento, agonista del receptor de grelina, propiedades del ibutamoren, cómo funciona el MK677, farmacología del ibutamoren, receptor GHS-R1a, estructura molecular, estudios clínicos, secreción de hormona de crecimiento, niveles de IGF-1, metabolismo de glucosa, resistencia a la insulina, información de seguridad.

Argentina

Biochem Ibutamoren 10 mg Argentina, Ibutamoren MK677 Argentina, Ibutamoren 100 cápsulas, ibutamoren 10 mg, secretagogo de hormona de crecimiento, agonista del receptor de grelina, propiedades del ibutamoren, qué es el MK677, mecanismo de acción del ibutamoren, receptor GHS-R1a, estructura molecular, estudios clínicos, hormona de crecimiento, IGF-1, metabolismo de glucosa, información de seguridad.

México

Biochem Ibutamoren 10 mg México, Ibutamoren MK677 México, Ibutamoren 100 cápsulas, ibutamoren 10 mg, secretagogo de hormona de crecimiento, agonista del receptor de grelina, propiedades del ibutamoren, para qué se investigó el MK677, cómo funciona el ibutamoren, farmacología del MK677, receptor GHS-R1a, estructura molecular, estudios clínicos, niveles de IGF-1, resistencia a la insulina, evidencia clínica limitada.

Perú

Biochem Ibutamoren 10 mg Perú, Ibutamoren MK677 Perú, Ibutamoren 100 cápsulas, ibutamoren 10 mg, secretagogo de hormona de crecimiento, agonista del receptor de grelina, propiedades del ibutamoren, mecanismo de acción del MK677, farmacología del ibutamoren, receptor GHS-R1a, estructura molecular, estudios clínicos, secreción de hormona de crecimiento, niveles de IGF-1, metabolismo de glucosa, información de seguridad.

Venezuela

Biochem Ibutamoren 10 mg Venezuela, Ibutamoren MK677 Venezuela, Ibutamoren 100 cápsulas, ibutamoren 10 mg, secretagogo de hormona de crecimiento, agonista del receptor de grelina, propiedades del ibutamoren, qué es el MK677, cómo actúa el ibutamoren, farmacología del MK677, receptor GHS-R1a, estructura molecular, estudios clínicos, niveles de IGF-1, resistencia a la insulina, evidencia clínica limitada.

Ecuador

Biochem Ibutamoren 10 mg Ecuador, Ibutamoren MK677 Ecuador, Ibutamoren 100 cápsulas, ibutamoren 10 mg, secretagogo de hormona de crecimiento, agonista del receptor de grelina, propiedades del ibutamoren, cómo funciona el MK677, farmacología del ibutamoren, mecanismo de acción, receptor GHS-R1a, estructura molecular, estudios clínicos, hormona de crecimiento, IGF-1, metabolismo de glucosa, información de seguridad.

Biochem Ibutamoren (MK-677) 10mg | 100 Capsules | Growth Hormone Secretagogue

Learn about Biochem Ibutamoren MK-677 10mg, 100 capsules. This product contains ibutamoren, an oral ghrelin receptor agonist studied for growth hormone and IGF-1 regulation, with important metabolic safety concerns and no established approved therapeutic use.

Biochem Ibutamoren (MK-677) 10mg | 100 Cápsulas | Secretagogo de Hormona de Crecimiento

Conoce Biochem Ibutamoren MK-677 10mg, 100 cápsulas. Este producto contiene ibutamoren, un agonista oral del receptor de grelina estudiado por sus efectos sobre la hormona de crecimiento y el IGF-1, con importantes riesgos metabólicos y sin uso terapéutico aprobado establecido.

biochem-ibutamoren-mk677-10mg-100-capsules

biochem-ibutamoren-mk677-10mg-100-capsulas

Biochem Ibutamoren MK-677 10mg, 100 oral capsules containing ibutamoren, a nonpeptide growth hormone secretagogue and ghrelin receptor agonist associated with growth hormone and IGF-1 signaling research.

Biochem Ibutamoren MK-677 10mg, 100 cápsulas orales que contienen ibutamoren, un secretagogo no peptídico de hormona de crecimiento y agonista del receptor de grelina relacionado con investigaciones sobre señalización de hormona de crecimiento e IGF-1.